Cargando…
Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape
SARS-CoV-2 variants of concern exhibit varying degrees of transmissibility and, in some cases, escape from acquired immunity. Much effort has been devoted to measuring these phenotypes, but understanding their impact on the course of the pandemic—especially that of immune escape—has remained a chall...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603072/ https://www.ncbi.nlm.nih.gov/pubmed/34910927 http://dx.doi.org/10.1016/j.cell.2021.11.026 |
_version_ | 1784601698629582848 |
---|---|
author | Bushman, Mary Kahn, Rebecca Taylor, Bradford P. Lipsitch, Marc Hanage, William P. |
author_facet | Bushman, Mary Kahn, Rebecca Taylor, Bradford P. Lipsitch, Marc Hanage, William P. |
author_sort | Bushman, Mary |
collection | PubMed |
description | SARS-CoV-2 variants of concern exhibit varying degrees of transmissibility and, in some cases, escape from acquired immunity. Much effort has been devoted to measuring these phenotypes, but understanding their impact on the course of the pandemic—especially that of immune escape—has remained a challenge. Here, we use a mathematical model to simulate the dynamics of wild-type and variant strains of SARS-CoV-2 in the context of vaccine rollout and nonpharmaceutical interventions. We show that variants with enhanced transmissibility frequently increase epidemic severity, whereas those with partial immune escape either fail to spread widely or primarily cause reinfections and breakthrough infections. However, when these phenotypes are combined, a variant can continue spreading even as immunity builds up in the population, limiting the impact of vaccination and exacerbating the epidemic. These findings help explain the trajectories of past and present SARS-CoV-2 variants and may inform variant assessment and response in the future. |
format | Online Article Text |
id | pubmed-8603072 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Author(s). Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86030722021-11-19 Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape Bushman, Mary Kahn, Rebecca Taylor, Bradford P. Lipsitch, Marc Hanage, William P. Cell Article SARS-CoV-2 variants of concern exhibit varying degrees of transmissibility and, in some cases, escape from acquired immunity. Much effort has been devoted to measuring these phenotypes, but understanding their impact on the course of the pandemic—especially that of immune escape—has remained a challenge. Here, we use a mathematical model to simulate the dynamics of wild-type and variant strains of SARS-CoV-2 in the context of vaccine rollout and nonpharmaceutical interventions. We show that variants with enhanced transmissibility frequently increase epidemic severity, whereas those with partial immune escape either fail to spread widely or primarily cause reinfections and breakthrough infections. However, when these phenotypes are combined, a variant can continue spreading even as immunity builds up in the population, limiting the impact of vaccination and exacerbating the epidemic. These findings help explain the trajectories of past and present SARS-CoV-2 variants and may inform variant assessment and response in the future. The Author(s). Published by Elsevier Inc. 2021-12-22 2021-11-19 /pmc/articles/PMC8603072/ /pubmed/34910927 http://dx.doi.org/10.1016/j.cell.2021.11.026 Text en © 2021 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Bushman, Mary Kahn, Rebecca Taylor, Bradford P. Lipsitch, Marc Hanage, William P. Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape |
title | Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape |
title_full | Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape |
title_fullStr | Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape |
title_full_unstemmed | Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape |
title_short | Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape |
title_sort | population impact of sars-cov-2 variants with enhanced transmissibility and/or partial immune escape |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603072/ https://www.ncbi.nlm.nih.gov/pubmed/34910927 http://dx.doi.org/10.1016/j.cell.2021.11.026 |
work_keys_str_mv | AT bushmanmary populationimpactofsarscov2variantswithenhancedtransmissibilityandorpartialimmuneescape AT kahnrebecca populationimpactofsarscov2variantswithenhancedtransmissibilityandorpartialimmuneescape AT taylorbradfordp populationimpactofsarscov2variantswithenhancedtransmissibilityandorpartialimmuneescape AT lipsitchmarc populationimpactofsarscov2variantswithenhancedtransmissibilityandorpartialimmuneescape AT hanagewilliamp populationimpactofsarscov2variantswithenhancedtransmissibilityandorpartialimmuneescape |